Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

Presentation TCT 2024

TCT 846: Association of Cerebral Embolic Protection Device Use With Disabling Stroke After Transcatheter Aortic Valve Replacement: Insights From the National Inpatient Sample

Presenter: Jerry Lipinski

October 30, 2024

Presentation TCT 2024

Cerebral Embolic Protection in the US Cohort of the PROTECTED TAVR Trial

Presenter: Samir Kapadia

October 29, 2024

Presentation TCT 2024

Case: Evolving Stroke After TAVR

Presenter: Jason Bloom

October 28, 2024

Presentation TCT 2024

Incidence, Diagnosis, and Management of Evolving Strokes After TAVR

Presenter: Julia Seeger

October 28, 2024

Presentation TCT 2024

A Sensible Approach to CEP for TAVR: From Clinical Trials to Clinical Practices

Presenter: Aakriti Gupta

October 28, 2024

Presentation TCT 2024

The Role of Cerebral Embolic Protection in TAVR

Presenter: Samir Kapadia

October 28, 2024

Presentation TCT 2024

Short- and Long-Term Effect of Cerebral Embolic Protection Device on New Brain Lesions Following Transcatheter Aortic-Valve Replacement: The Sentinel Registry (Sentinel)

Presenter: Han Su Park

October 27, 2024

Presentation NY Valves 2024

First-in-Human Experience With the EnCompass F2 Filter, a Novel Cerebral Embolic Protection Device for TAVR

Presenter: Tamim M. Nazif

June 07, 2024

Presentation NY Valves 2024

The Promise of Next Generation Cerebral Embolic Protection Devices

Presenter: Tamim M. Nazif

June 05, 2024

Presentation NY Valves 2024

Modern Era Clinical Trial Strategies For Cerebral Embolic Protection Devices

Presenter: Alexandra J. Lansky

June 05, 2024

Presentation NY Valves 2024

Practical Tips for Cerebral Embolic Protection: From Clinical Trials to Clinical Practice

Presenter: Amar Krishnaswamy

June 05, 2024

Presentation NY Valves 2024

Impact of Cerebral Embolic Protection Devices on Disabling Stroke After Transcatheter Aortic Valve Replacement: Results From the STS/ACC TVT Registry

Presenter: Neel Butala

June 05, 2024

Advertisement

TCT 846: Association of Cerebral Embolic Protection Device Use With Disabling Stroke After Transcatheter Aortic Valve Replacement: Insights From the National Inpatient Sample

Cerebral Embolic Protection in the US Cohort of the PROTECTED TAVR Trial

Case: Evolving Stroke After TAVR

Incidence, Diagnosis, and Management of Evolving Strokes After TAVR

A Sensible Approach to CEP for TAVR: From Clinical Trials to Clinical Practices

The Role of Cerebral Embolic Protection in TAVR

Short- and Long-Term Effect of Cerebral Embolic Protection Device on New Brain Lesions Following Transcatheter Aortic-Valve Replacement: The Sentinel Registry (Sentinel)

First-in-Human Experience With the EnCompass F2 Filter, a Novel Cerebral Embolic Protection Device for TAVR

The Promise of Next Generation Cerebral Embolic Protection Devices

Modern Era Clinical Trial Strategies For Cerebral Embolic Protection Devices

Practical Tips for Cerebral Embolic Protection: From Clinical Trials to Clinical Practice

Impact of Cerebral Embolic Protection Devices on Disabling Stroke After Transcatheter Aortic Valve Replacement: Results From the STS/ACC TVT Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content